End-respiratory pressure ventilation and sulfobromophthalein sodium excretion in dogs.
Sulfobromophthalein sodium (BSP) 25 mg/kg body wt was given as a single iv injection to 32 fasted dogs. Serum samples at 3, 5, 10, 20, 30, 45, 60, 80, and 120 min postinjection were analyzed for total concentration of BSP and from 30 to 120 min for percent conjugated BSP. Four groups were compared: spontaneous ventilation; intermittent positive-pressure ventilation (IPPV) and continuous positive-pressure ventilation (CPPV) (2 groups). During CPPV, one group of dogs was given a continuous infusion of cholecystokinin octapeptide (CCK-8, 1 ng/kg per min). Central venous pressure averaged 11.3 +/- 0.7 (SE) cmH2O in dogs with CPPV + CCK-8 and 11.8 +/- 0.8 (SE) cmH2O in dogs with CPPV alone. At 3, 5, and 10 min postinjection serum BSP levels were similar in all groups. From 30 to 120 min postinjection serum levels of both free and conjugated BSP were higher in dogs ventilated with CPPV alone than in any other group (P less than 0.01). Dogs given CCK-8 during CPPV had serum BSP levels that were statistically similar to dogs breathing spontaneously or ventilated with IPPV. We conclude that CPPV impairs BSP excretion. This effect is counteracted by CCK-8.
D000403:Airway Resistance; D000818:Animals; D001784:Blood Gas Analysis; D002496:Central Venous Pressure; D002766:Cholecystokinin / Q000494:pharmacology*; D004285:Dogs; D008099:Liver / Q000378:metabolism*; D008657:Metabolic Clearance Rate; D012119:Respiration; D013448:Sulfobromophthalein / Q000097:blood*; D013997:Time Factors
D013448:Sulfobromophthalein; D002766:Cholecystokinin